Ken MacLeod
InvestorPartner at Rosetta Capital Ltd.
About
Kenneth MacLeod joined Rosetta Capital as a Partner in 2021, bringing over 35 years of life sciences experience across operating roles at healthcare companies (Abbott Labs., Serono) and fund management (SV Health Investors, Paul Capital, Visium Healthcare Partners). He holds board seats at JenaValve Technologies and Oxular, and holds a BSc from the University of Manchester and a D.Phil from the University of York.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
JenaValve Technologies, inc.On-X Life Technologies, Inc.Oxular LimitedPharming Group N.V.SpePharm Holding B.V.
Per the firm's website.
Colleagues at Rosetta Capital Ltd.
Frequently asked questions
- Who is Ken MacLeod?
- Kenneth MacLeod joined Rosetta Capital as a Partner in 2021, bringing over 35 years of life sciences experience across operating roles at healthcare companies (Abbott Labs., Serono) and fund management (SV Health Investors, Paul Capital, Visium Healthcare Partners). He holds board seats at JenaValve Technologies and Oxular, and holds a BSc from the University of Manchester and a D.Phil from the University of York.
- Where does Ken MacLeod work?
- Ken MacLeod is Partner at Rosetta Capital Ltd..
- What does Ken MacLeod invest in?
- Ken MacLeod invests in Biotech, Healthtech, Medical Devices.
- What boards does Ken MacLeod sit on?
- Ken MacLeod holds tracked board seats at JenaValve Technologies, inc., On-X Life Technologies, Inc., Oxular Limited, Pharming Group N.V., SpePharm Holding B.V..